View Full Text | Abstract |
Article as PDF | Print this Article |
Pubmed | PMC |
PubReader | Export to Citation |
Email Alerts | Open Access |
Exp Neurobiol 2017; 26(2): 97-103
Published online April 30, 2017
https://doi.org/10.5607/en.2017.26.2.97
© The Korean Society for Brain and Neural Sciences
Cheng Qi1, Scott Varga1, Soo-Jin Oh2,3, C. Justin Lee3 and Daewoo Lee1*
1Neuroscience Program, Department of Biological Sciences, Ohio University, Athens, OH 45701, USA, 2Convergence Research Center for Diagnosis, Treatment and Care System of Dementia, 3Center for Neuroscience, Center for Functional Connectomics, Korea Institute of Science and Technology (KIST), Seoul 02792, Korea
Correspondence to: *To whom correspondence should be addressed.
TEL: 1-740-597-1926, FAX: 1-740-593-0300
e-mail: leed1@ohio.edu
α-Synuclein (α-Syn) is a small presynaptic protein and its mutant forms (e.g. A53T) are known to be directly associated with Parkinson's disease (PD). Pathophysiological mechanisms underlying α-Syn-mediated neurodegeneration in PD still remain to be explored. However, several studies strongly support that overexpression of mutant α-Syn causes reduced release of dopamine (DA) in the brain, and contributes to motor deficits in PD. Using a favorable genetic model
Keywords: α-Synuclein, EKO, optogenetics, Parkinson’s disease, Dopaminergic neurons, Drosophila melanogaster